Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity.

Literature DB >> 3023864

The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity.

Abstract

The activity of the hepatitis B viral enhancer element was studied in various cell lines. This enhancer shows strict host and tissue specificity in that it is functional only in liver cells of human origin. Further, it requires trans-acting factor(s) present in liver cells for activity, and this activity is independent of hepatitis B virus gene products in the cell lines tested.

Entities: Disease Species

Mesh：

Substances：

Year: 1986 PMID： 3023864 PMCID： PMC367563 DOI： 10.1128/mcb.6.2.710-715.1986

Source DB: PubMed Journal: Mol Cell Biol ISSN： 0270-7306 Impact factor: 4.272

24 in total

Review 1. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors: W Szmuness
Journal: Prog Med Virol Date: 1978

2. A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors: F L Graham; A J van der Eb
Journal: Virology Date: 1973-04 Impact factor: 3.616

3. The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants.

Authors: P Moreau; R Hen; B Wasylyk; R Everett; M P Gaub; P Chambon
Journal: Nucleic Acids Res Date: 1981-11-25 Impact factor: 16.971

4. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

Authors: J Banerji; S Rusconi; W Schaffner
Journal: Cell Date: 1981-12 Impact factor: 41.582

5. Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences.

Authors: M Lusky; M Botchan
Journal: Nature Date: 1981-09-03 Impact factor: 49.962

6. In vivo sequence requirements of the SV40 early promotor region.

Authors: C Benoist; P Chambon
Journal: Nature Date: 1981-03-26 Impact factor: 49.962

7. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors: P J Southern; P Berg
Journal: J Mol Appl Genet Date: 1982

8. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors: B B Knowles; C C Howe; D P Aden
Journal: Science Date: 1980-07-25 Impact factor: 47.728

9. Simian virus 40 tandem repeated sequences as an element of the early promoter.

Authors: P Gruss; R Dhar; G Khoury
Journal: Proc Natl Acad Sci U S A Date: 1981-02 Impact factor: 11.205

10. Enhancer activity correlates with the oncogenic potential of avian retroviruses.

Authors: F Weber; W Schaffner
Journal: EMBO J Date: 1985-04 Impact factor: 11.598

49 in total

1. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice.

Authors: R D Burk; J A DeLoia; M K elAwady; J D Gearhart
Journal: J Virol Date: 1988-02 Impact factor: 5.103

The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity.

Review 1. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

2. A new technique for the assay of infectivity of human adenovirus 5 DNA.

3. The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants.

4. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

5. Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences.

6. In vivo sequence requirements of the SV40 early promotor region.

7. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

8. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

9. Simian virus 40 tandem repeated sequences as an element of the early promoter.

10. Enhancer activity correlates with the oncogenic potential of avian retroviruses.

1. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice.

2. trans-activation of viral enhancers by the hepatitis B virus X protein.

3. Expression of hepatitis B viral core region in mammalian cells.

4. Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer.

5. Transcriptional activation and repression by cellular DNA-binding protein C/EBP.

6. Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.

Review 7. Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

8. White spot syndrome virus annexes a shrimp STAT to enhance expression of the immediate-early gene ie1.

Review 9. Regulatory mechanisms of viral hepatitis B and C.

10. Replicative intermediate of hepatitis B virus in transfected murine fibroblasts.